Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />
Exhibitor Hosted Session Index<br />
EXHIBITOR HOSTED SESSIONS<br />
(Listed by date and time, then alphabetically by presenter)<br />
Exhibitor Hosted Sessions are informative sessions developed by<br />
an exhibiting company.<br />
Monday<br />
Time: 9:15 AM–10:15 AM<br />
Presented by Topic Room Page<br />
Charles River<br />
Phototoxicology: Current Practices<br />
and Regulatory Status<br />
140A 122<br />
MPI Research Logistic and Technical Challenges 156 122<br />
<strong>of</strong> Conducting Developmental<br />
Toxicity Studies in Nonhuman<br />
Primates<br />
Time: 10:30 AM–11:30 AM<br />
Presented by Topic Room Page<br />
Harlan<br />
Laboratories,<br />
Inc.<br />
Huntingdon Life<br />
Sciences<br />
From Guidelines to Protocol:<br />
Lessons from EDSP Validation<br />
First in Human Monoclonal<br />
Antibody Development Strategies<br />
for the Treatment <strong>of</strong> Cancer<br />
Patients<br />
140B 150<br />
156 149<br />
Time: 11:45 AM–12:45 PM<br />
Presented by Topic Room Page<br />
Porsolt &<br />
Partners<br />
Pharmacology<br />
Rules-Based<br />
Medicine, Inc.<br />
Sigma Life<br />
Science<br />
Nonclinical Evaluation <strong>of</strong><br />
Drug-Abuse Liability<br />
Urine and Blood Based Biomarkers<br />
for Detecting Nephrotoxicity<br />
Knockout Rats As More Effective<br />
Preclinical Models<br />
140A 150<br />
156 150<br />
140B 150<br />
Time: 2:15 PM–3:15 PM<br />
Presented by Topic Room Page<br />
SNBL USA, Ltd<br />
STEMCELL<br />
Technologies<br />
Inc.<br />
Nonhuman Primate (NHP) Infant<br />
Age and Relevance <strong>of</strong> Postnatal<br />
and Juvenile Assessments:<br />
Principles for Understanding<br />
Specific Endpoints in Study<br />
Designs Supporting Biologics<br />
Regulatory Submissions<br />
Utility <strong>of</strong> Hematopoietic Colony<br />
Forming Cell (CFC) Assays in Drug<br />
Development<br />
140B 191<br />
156 191<br />
Time: 3:30 PM–4:30 PM<br />
Presented by Topic Room Page<br />
In Vitro ADMET<br />
Laboratories,<br />
LLC (IVAL)<br />
U.S.<br />
Environmental<br />
Protection<br />
Agency<br />
Screening <strong>of</strong> Drug Candidates with<br />
Idiosyncratic Hepatoxic Potential:<br />
Concepts and Approaches<br />
Announcing EPA’s Clean Air<br />
Research Centers: Science to<br />
Protect Health in a Multipollutant<br />
Atmosphere<br />
Tuesday<br />
140A 191<br />
140B 191<br />
Time: 9:15 AM–10:15 AM<br />
Presented by Topic Room Page<br />
Celsis In Vitro<br />
Technologies<br />
Charles River<br />
LiverPool: Pooled Human<br />
Cryopreserved Hepatocytes and<br />
Their Advantages Across Diverse<br />
ADME-Tox Applications<br />
Preclinical Cellular Therapeutic<br />
Safety Testing<br />
140B 229<br />
140A 229<br />
MPI Research Predicting the Human Clinical 156 229<br />
Dose<br />
Time: 10:30 AM–11:30 AM<br />
Presented by Topic Room Page<br />
Harlan<br />
Laboratories,<br />
Inc.<br />
Huntingdon Life<br />
Sciences<br />
National<br />
<strong>Toxicology</strong><br />
<strong>Program</strong><br />
Diets for GLP Studies, Including<br />
Those for REACH<br />
Developing a Noval Vaccine/<br />
Adjuvant Combination for the<br />
Prophylaxis and Treatment <strong>of</strong><br />
Infectious Disease<br />
National <strong>Toxicology</strong> <strong>Program</strong><br />
Chemical Effects in Biological<br />
Systems<br />
140B 229<br />
156 229<br />
140A 229<br />
Time: 11:45 AM–12:45 PM<br />
Presented by Topic Room Page<br />
Data Sciences<br />
International<br />
Ingenuity<br />
Systems, Inc.<br />
LAB Research,<br />
Inc.<br />
New Applications <strong>of</strong> Latest<br />
Telemetry Technology in<br />
<strong>Toxicology</strong> and Safety<br />
Pharmacology<br />
A Systems <strong>Toxicology</strong> Approach to<br />
Understanding Drug Toxicity and<br />
Compound Prioritization<br />
A Battery <strong>of</strong> Toxicity Screening<br />
Assays for Selection <strong>of</strong> Dermal<br />
Drug Candidates<br />
140B 230<br />
156 230<br />
140A 229<br />
Toxexpo<br />
WIL Research<br />
Laboratories<br />
How to Comply with the EPA’s<br />
Endocrine Disruption Screening<br />
<strong>Program</strong><br />
140A 190<br />
ToxExpo Directories are available at Registration and just inside the entrance <strong>of</strong> the Exhibit Hall.<br />
up-to-date www.toxexpo.com information at www.toxicology.org<br />
41
Change language